Biogen, Inc. (BIIB)
192.96
-2.38
(-1.22%)
USD |
NASDAQ |
Jun 08, 14:30
Biogen Total Assets (Quarterly) : 29.48B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 56.28B |
| AbbVie, Inc. | 136.46B |
| Amgen, Inc. | 92.50B |
| Regeneron Pharmaceuticals, Inc. | 40.87B |
| Ionis Pharmaceuticals, Inc. | 3.450B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.83B |
| Shareholders Equity (Quarterly) | 18.65B |
| Debt to Equity Ratio | 0.3518 |
| Current Ratio | 3.065 |
| Net Debt Paydown Yield | 0.11% |